Jason George
Nephrology · Danville, PANPI 1578803698
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,500 of the $14,949 with a category attached, or 76.9%. Amgen accounts for 98.1% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $7,774, more than ten times the $27 reported in 2021. Among nephrology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $453.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$15K
- Actelion Pharmaceuticals US, Inc.$96
- Nxstage Medical, Inc.$73
- Travere Therapeutics, Inc.$45
- Calliditas Therapeutics US Inc.$39
- Novartis$35
Across 2 payments — averaging $4100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$8K
What the payments were for
- Speaking & faculty fees$11,50077%
- Travel & lodging$2,53117%
- Food & beverage$9196%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $14,662 |
| Actelion Pharmaceuticals US, Inc. | 3 | $96 |
| Nxstage Medical, Inc. | 4 | $73 |
| Travere Therapeutics, Inc. | 2 | $45 |
| Calliditas Therapeutics US Inc. | 1 | $39 |
| Novartis | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tavneos$13,393
How this compares
$14,949 in reported general payments places this provider in the 90th percentile of 586 nephrology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 25 | $29,970 |
| LokelmaSodium Zirconium Cyclosilicate | 35 | $29,787 |
| ProsolParenteral Amino Acid 20% No.1 | 178 | $28,519 |
| Lanthanum Carbonate | 11 | $12,586 |
| ProcritEpoetin Alfa | 14 | $10,538 |
| Calcium Acetate | 107 | $6,804 |
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 18 | $4,162 |
| Sevelamer Carbonate | 40 | $3,755 |
| Potassium Citrate ErPotassium Citrate | 24 | $3,661 |
| Midodrine Hcl | 36 | $2,350 |
| Tacrolimus | 18 | $2,108 |
| Torsemide | 74 | $1,331 |
| Amlodipine Besylate | 155 | $1,194 |
| Losartan Potassium | 90 | $1,133 |
| Carvedilol | 132 | $1,104 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Danville
- Prince AnandDanville$331K
- Kartik KalraDanville$108K
- Alexander ChangDanville$17K
- Evan NorfolkDanville$9K
- Nelson KopytAllentown$949K
- Christopher GislerPittsburgh$757K
- Rakesh GulatiPhiladelphia$657K
- Raymond TownsendPhiladelphia$357K
- Ellie KelepourisPhiladelphia$287K
- Jonathan DiamondHarrisburg$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.